Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial By: Philadelphia Business Journal via Business Journals April 08, 2022 at 12:15 PM EDT A Conshohocken firm received approval for a cancer therapy from the European Commission. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
